Investing.com -- Arvinas, Inc. (NASDAQ:ARVN) shares fell sharply by 29% as the market reacted to the company’s announcement of a significant workforce reduction and the removal of two Phase 3 trials from its development plan. Despite reporting positive topline results from the Phase 3 VERITAC-2 trial and presenting promising data for its neuroscience program, the clinical-stage biotechnology fir ...
(Reuters) -Three of India’s top four carmakers reported weak sales to dealers in April, company data showed on Thursday, as buyers delayed purchases amid concerns about slowing economic growth. Market leader Maruti Suzuki posted a marginal 0.6% year-on-year rise, while Hyundai Motor (OTC:HYMTF) India and Tata Motors (NYSE:TTM) clocked declines of 11.6% and 5.1%, respectively. Mahindra & M ...
By Aditya Kalra and Abhijith Ganapavaram NEW DELHI (Reuters) -Air India expects to face around $600 million in additional costs if a ban from Pakistan’s airspace lasts for a year, and has asked the federal government to compensate it for the hit, a company letter seen by Reuters shows. Indian airlines are bracing for higher fuel costs and longer journey times after Pakistan shut its airspace to ...
By Mariam Sunny and Christy Santhosh (Reuters) - Biogen (NASDAQ:BIIB) beat first-quarter profit and revenue expectations on Thursday, as strong demand for its rare disease drugs helped offset declining sales of its multiple sclerosis medicines. The drugmaker has focused on deals, cost-cutting measures and newer drugs to address investor pressure for growth as demand falls for its once top-selling ...